Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland.

Background-Homozygosity for a relatively common Cys282Tyr mutation of the human hemochromatosis-associated (HFE) gene was recently found to account for most cases of hereditary hemochromatosis. Because excess iron has been postulated to enhance risk of vascular disease, we studied whether occurrence of this mutation was associated with increased risk of first acute myocardial infarction in healthy middle-aged men in a prospective cohort study. Methods and Results-Study subjects were the 1150 participants in the population-based Kuopio Ischemic Heart Disease Risk Factor Study (KIHD), aged 42, 48, 54, or 60 years at baseline, who had no coronary heart disease at baseline and for whom a DNA sample was available. Information about myocardial infarctions was collected prospectively by use of FINMONICA (FINnish MONItoring of trends and determinants in CArdiovascular disease study) and hospital data. Events were classified by MONICA (MONItoring of trends and determinants in CArdiovascular disease study) diagnostic criteria. The HFE Cys282Tyr mutation was assayed by a solid-phase minisequencing technique. One subject was homozygous and 76 individuals were heterozygous for the HFE Cys282Tyr mutation (6.7%). During a mean follow-up of 9 years, 8 (10.4%) of 77 carriers and 60 (5.6%) of 1073 noncarriers experienced an acute myocardial infarction. In a Cox proportional hazards model allowing for the other strongest risk factors, the carriers had a 2.3-fold (95% CI 1. 1 to 4.8; P=0.03) risk of acute myocardial infarction compared with noncarriers. Conclusions-Male carriers of the common hemochromatosis gene mutation are at 2-fold risk for first acute myocardial infarction compared with noncarriers.

[1]  Trip,et al.  Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease , 1998, British journal of haematology.

[2]  T. Lakka,et al.  Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study. , 1998, American journal of epidemiology.

[3]  Tzong-Shyuan Lee,et al.  Colocalization of iron and ceroid in human atherosclerotic lesions. , 1998, Atherosclerosis.

[4]  J. Salonen,et al.  Association between body iron stores and the risk of acute myocardial infarction in men. , 1998, Circulation.

[5]  W. Sly,et al.  HFE gene knockout produces mouse model of hereditary hemochromatosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. M. Penny,et al.  The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  I. Bata,et al.  Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. , 1998, The Canadian journal of cardiology.

[8]  S. Chakrabarti,et al.  Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. , 1998, Gastroenterology.

[9]  C. Férec,et al.  Phenotype-genotype correlation in haemochromatosis subjects , 1997, Human Genetics.

[10]  W. Sly,et al.  Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Wolff,et al.  The Hemochromatosis Founder Mutation in HLA-H Disrupts β2-Microglobulin Interaction and Cell Surface Expression* , 1997, The Journal of Biological Chemistry.

[12]  Jennifer J. Pointon,et al.  Global prevalence of putative haemochromatosis mutations. , 1997, Journal of medical genetics.

[13]  H. Parving,et al.  Population based study of rates of multiple pregnancies in denmark, 1980-94 , 1997, BMJ.

[14]  J. Salonen,et al.  First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome , 1997, BMJ.

[15]  W. Sly,et al.  Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with b2-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells (degradationyGolgi processingyintracellular transportyironymajor histocompatibility complex class I protein) , 1997 .

[16]  L. Jorde,et al.  Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. , 1996, The New England journal of medicine.

[17]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[18]  W. Crosby,et al.  Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. , 1996, Clinica chimica acta; international journal of clinical chemistry.

[19]  N. Asp,et al.  Iron nutrition in health and disease. , 1996 .

[20]  J. Salonen,et al.  Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men , 1995, BMJ.

[21]  J. Gutteridge,et al.  Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material , 1995, FEBS letters.

[22]  M. Mutanen,et al.  Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. , 1995, Circulation.

[23]  P. Adams.  Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: An analysis of 255 heterozygotes , 1994, American journal of hematology.

[24]  J. Salonen.  The role of iron as a cardiovascular risk factor , 1993 .

[25]  J. Kushner,et al.  Screening for hemochromatosis. , 1993, The New England journal of medicine.

[26]  H. Macdonald.  High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. , 1993, Circulation.

[27]  O. Aruoma,et al.  Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. , 1992, The Biochemical journal.

[28]  K Kontula,et al.  A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. , 1990, Genomics.

[29]  J. Sullivan.  Heterozygous hemochromatosis as a risk factor for premature myocardial infarction. , 1990, Medical hypotheses.

[30]  J. Tuomilehto,et al.  WHO MONICA Project: assessing CHD mortality and morbidity. , 1989, International journal of epidemiology.

[31]  A. Reunanen,et al.  Prevalence of hemochromatosis in Finland. , 2009, Acta medica Scandinavica.

[32]  G. Gross,et al.  Evidence For a Role of Iron‐Catalyzed Oxidants in Functional and Metabolic Stunning in the Canine Heart , 1988, Circulation research.

[33]  M. Skolnick,et al.  Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. , 1988, The New England journal of medicine.

[34]  Salonen Jt.  Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. , 1988 .

[35]  J. Salonen,et al.  Is there a continuing need for longitudinal epidemiologic research? The Kuopio Ischaemic Heart Disease Risk Factor Study. , 1988, Annals of clinical research.

[36]  J. Salonen,et al.  An automated colorimetric assay for urine nicotine metabolites: a suitable alternative to cotinine assays for the assessment of smoking status. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[37]  M. Weisfeldt,et al.  Improvement of postischemic myocardial function and metabolism induced by administration of deferoxamine at the time of reflow: the role of iron in the pathogenesis of reperfusion injury. , 1987, Circulation.

[38]  A. Sonnenberg,et al.  Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. , 1985, The New England journal of medicine.